JAKARTA — Indonesia will have capacity to produce 250 million doses a year of a coronavirus vaccine by the end of 2020 pending trials on humans, a minister said on Tuesday, as the country seeks to halt a wave of infections that has shown no sign of relent. Indonesia has confirmed 115,056 cases of COVID-19 and 5,388 deaths since its first infections in March. State-run pharmaceutical firm Bio Farma will begin phase three of clinical trials in humans this week using a vaccine produced by China's Sinovac. If those are successful, Bio Farma has said would produce the vaccine itself. The global pandemic has sparked a scramble to create a vaccine, with more than 100 in development and about a dozen already being tested on humans.

Source: International New York Times August 04, 2020 13:41 UTC